Navigation Links
Small Spreads of Breast Cancer May Not Affect Survival
Date:1/20/2011

By Kathleen Doheny
HealthDay Reporter

WEDNESDAY, Jan. 19 (HealthDay News) -- For decades, doctors have debated about how to best determine whether a patient's breast cancer has spread, especially in the earliest cases of metastases.

Now, researchers have compared two approaches -- a sentinel lymph node biopsy alone, or the sentinel biopsy combined with axillary dissection, which is a more invasive procedure that can spot hidden, smaller metastases. The finding: As long as the larger metastases (2 millimeters in diameter and up) are found, the outcomes of the two procedures are similar.

"What we showed was the significance of these small micrometastases is very small," explained study author Dr. Donald L. Weaver, a professor of pathology at the University of Vermont College of Medicine and Vermont Cancer Center. The report is published in the Jan. 19 online edition of the New England Journal of Medicine.

Weaver and his team randomly assigned 5,611 women with breast cancer but clinically negative axillary nodes to one of two groups -- about half underwent the sentinel node biopsy alone and the other half underwent the biopsy plus axillary dissection.

A sentinel lymph node is the first lymph node to which cancer is likely to spread. The biopsy is based on the idea that cancer cells metastasize in an orderly fashion.

At the centers participating in the study, the sentinel node exam was designed to find all metastases more than 2 millimeters in dimension, known as macrometastases.

Follow-up data was available for 1,924 in the combination group and 1,960 in the biopsy-only group. In the biopsy-only group, 300 were positive for metastases, while 316 were positive in the combination group.

Of those who had metastases, 172 were micrometastases, 14 had macrometastases and 430 had even tinier spreads, known as isolated tumor-cell clusters, the study authors found.

The researchers looked at differences in the patients in whom the hidden metastases were found and in those in which they weren't found. They compared overall survival, disease-free survival and distant-disease-free survival.

"If you had them, the [overall] survival was 94.6 percent; if not, 95.8. There's only a 1.2 percent difference between the two," Weaver said.

While the difference was significant from a statistical point of view, it was slight from a clinical point of view, he noted.

For women, Weaver said, the take-home message is not to be concerned about metastases being missed, provided the sentinel lymph node biopsy was done.

"Enough is enough as long as you find the macrometastases, the ones over 2 millimeters," he said.

As for the smaller spreads? "They are probably being treated by whatever cancer treatment is recommended [for the primary tumor]," he said, such as chemotherapy, endocrine therapy or radiation.

The new information "kind of solidifies an idea that we know," said Dr. Laura Kruper, an assistant professor of oncology and a breast cancer surgeon at the City of Hope Comprehensive Cancer Center in Duarte, Calif.

What the findings suggest, she said, is that the standard procedure followed by many -- do the sentinel lymph node biopsy alone if it's negative -- seems to be effective.

She added, however, that "we really do need to continue to follow these patients long-term" to see if the differences remain small.

More information

To learn more about sentinel lymph node biopsy, visit the U.S. National Cancer Institute.

SOURCES: Donald L. Weaver, M.D., professor, pathology, University of Vermont College of Medicine and Vermont Cancer Center, Burlington, Vt.; Laura Kruper, M.D., assistant professor, oncology, and breast cancer surgeon, City of Hope Comprehensive Cancer Center, Duarte, Calif.; Jan. 19, 2011, New England Journal of Medicine, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Small molecules may prevent ebola infection
2. MIT neuroscientists explain Proustian effect of small details attached to big memories
3. Deadliest Cancer Getting Smaller Chunk of Research Dollars
4. Small molecule may disarm enemy of cancer-fighting p53
5. Small assist device used in emergency case as twin, heart booster pumps for first time in US
6. Unexpectedly small effects of mutations in bacteria bring new perspectives
7. UCI non-small cell lung cancer study highlights advances in targeted drug therapy
8. Small particles show big promise in beating unpleasant odors
9. Small business success spotlighted by USDA at conference
10. American Chemical Society Webinar focuses on NSFs small business funding programs
11. Health Care Reform Helps Small Businesses Offer Coverage: Report
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Small Spreads of Breast Cancer May Not Affect Survival 
(Date:4/26/2017)... ... April 26, 2017 , ... Want to learn ... ( CRISPRCas.pioneer.com ) that demonstrates how this advanced plant breeding technology is a ... food, with fewer resources. It highlights the business’ principles, research and collaboration efforts ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... and collaboration, announces Mirroring360 Pro . This new addition to the Mirroring360 ... experience for education and business. , Mirroring360 Pro enables educators, business professionals and ...
(Date:4/25/2017)... CO (PRWEB) , ... April 25, 2017 , ... ... and Liberty attempts to compare student test score performance for the 2015-16 school ... of the state’s voucher programs. Though it highlights important patterns in student test ...
(Date:4/25/2017)... VIRGINIA (PRWEB) , ... April 25, 2017 , ... ... leading the way in unveiling cutting-edge birth defects research related to Zika virus ... by the world’s premier society for this important science. , The ...
(Date:4/25/2017)... ... , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley Bobrow will ... set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, FAHA, is ... of Medicine. He also serves as Medical Director for the Bureau of Emergency Medical ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Global Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, ... 2024" report to their offering. ... The global pharmacogenomics market was valued at US$ ... 11,938.8 Mn by 2024, expanding at a CAGR of 5.6% ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology: